Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.109 (
AST
)
6,066
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
1. GR95030X, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, was administered daily to marmosets by gavage. In a Maximum Repeatable Dose (MRD) study, doses of up to 30 mg kg-1 day-1 were administered for 49 days. In a chronic study, animals received dosages equivalent to 0, 1, 2.5, 7.5 and 20 mg kg-1 day-1 for 204 or 205 days. Some animals were maintained without treatment for a recovery period of 29 or 30 days. 2. Clinical signs included poor coat condition, weakness with impaired coordination, lethargy and other behavioural changes. There was also alimentary disturbance, and some deaths occurred at doses of 20 mg kg-1 day-1 and above. 3. Adverse effects upon body weight were seen although some recovery was apparent after the cessation of treatment. 4. Serum cholesterol concentrations were reduced. Very large increases in serum ALT,
AST
and CK activities were recorded with
CK-MM
isoenzymes accounting for 80% or more of the total CK enzyme activity. 5. Treatment was associated with muscle fibre atrophy and a sarcolemmal response with little evidence of regeneration. Histological examination revealed vascular changes, glial proliferation and cell death in the brain, with no consistent distribution. Alveolar capillary congestion and alveolar proteinosis indicated that there may have been a reduction in cardiac function. 6. HMG-CoA reductase inhibitors have evident potential to cause myopathy in marmosets. This is believed to be the first report of such an effect.
...
PMID:Toxicity of a novel HMG-CoA reductase inhibitor in the common marmoset (Callithrix jacchus). 804 18
1. The effects of simvastatin and pravastatin on measures of central nervous system activity were investigated in a double-blind, placebo-controlled, randomised crossover study. 2. Twenty-five healthy volunteers sequentially took 40 mg day-1 simvastatin, 40 mg day-1 pravastatin or placebo for 4 weeks, separated by a 4-6 week washout phase. 3. CNS measures included EEG evoked potentials, power spectral analysis, Leeds Sleep Questionnaire, Hospital Anxiety Depression (HAD) Scale, and Digit Symbol Substitution Test (DSST); biochemical measures included plasma cholesterol, liver enzymes (gamma-GT,
AST
, ALT) and
creatine kinase
. 4. Mean cholesterol concentrations with both drugs were significantly lower than with placebo, and the cholesterol-lowering effect was greater with simvastatin. There were no significant differences between treatment in EEG evoked potentials, HAD Scale, or DSST scores. On the sleep measure, subjects reported significantly greater difficulty in getting to sleep while on simvastatin than on pravastatin, but neither score differed from placebo. No significant correlations were observed between sleep ratings and either plasma cholesterol concentrations or EEG evoked potentials. 5. The study showed that, while both drugs reduced plasma cholesterol concentrations, neither exerted significant effects, compared with placebo, on EEG evoked potentials, mood, sleep, or cognitive performance after 4 weeks of chronic administration in healthy volunteers.
...
PMID:Do cholesterol-lowering agents affect brain activity? A comparison of simvastatin, pravastatin, and placebo in healthy volunteers. 819 30
A case of muscular dystrophy in a 1-year-old male castrated Domestic Shorthair cat is presented. The most striking clinical features were regurgitation, a stiff gait, an increased muscle tone and exercise intolerance. Serum biochemistry panels showed a marked increase in the muscle specific enzyme
creatine kinase
, and moderately elevated levels of LDH,
AST
and ALT. Spontaneous electrical activity of skeletal muscles in the form of "bizarre high frequency discharges" and "myotonia-like repetitive discharges" were registered. Gross pathology revealed a marked hypertrophy of the skeletal muscles. The main histopathological changes were myofiber necrosis and calcification, variation in fiber size, hypertrophied muscle fibers of type I and type II and fiber splitting. Indirect immunofluorescence showed dystrophin deficiency. Feline muscular dystrophy resembles the X-linked human Duchenne muscular dystrophy (DMD). Besides the X-linked muscular dystrophy in the mouse and Golden Retriever the feline muscular dystrophy could represent another valuable animal model for the study of DMD.
...
PMID:[Muscular dystrophy in a cat]. 824 6
Cell damage within the sinusoidal lining of human liver grafts during transplantation is an early event that is critical in ischemia-reperfusion injury and probably plays a key role in primary liver dysfunction after transplantation. No simple biochemical marker for sinusoidal injury is currently available. Because
creatine kinase
activity has been described in heart endothelial cells, we hypothesized that release of this enzyme might serve as an index of sinusoidal injury. To test this hypothesis, we used several in vivo and in vitro experimental models. Occlusion of the rat hepatic pedicle in situ for 60 min (normothermic ischemia) induced a significant increase in serum
creatine kinase
levels relative to those in laparotomized controls (2,530 +/- 530 vs. 389 +/- 64 IU/L, mean +/- SEM; p < 0.005). In the isolated perfused rat liver, 60-min ischemia induced early (< or = 3 min)
creatine kinase
and
AST
release (0.87 +/- 0.14 vs. 0.08 +/- 0.01 IU/min/gm liver, respectively). A similar phenomenon was observed after 24-hr or 48-hr hypothermic conservation in University of Wisconsin solution. Electrophoretic analysis and immunoinhibition studies showed that
creatine kinase
activity comprised
creatine kinase
-BB (approximately 50%) and mitochondrial
creatine kinase
. Trypan blue infusion showed a loss of viability in sinusoidal cells, whereas hepatocytes were relatively spared. Finally, murine sinusoidal cells were isolated, cultured and then lysed by a freeze-thaw cycle and sonication. Creatine kinase activity was found in endothelial cells (
creatine kinase
-BB), Kupffer cells (
creatine kinase
-BB) and Ito cells (
creatine kinase
-MM). Creatine kinase-BB was not found in hepatocytes, but mitochondrial
creatine kinase
was detected.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Creatine kinase-BB: a marker of liver sinusoidal damage in ischemia-reperfusion. 827 65
The concentrations of sodium, potassium, chloride, urea, creatinine, uric acid, total protein, albumin, inorganic phosphorous, calcium, magnesium, cholesterol, triglyceride, glucose, aspartate and alanine transaminases (
AST
and ALT),
creatine kinase
(CK), lactic acid dehydrogenase (LD), gamma-glutamyltransferase (GGT), alkaline phosphatase (ALP) and total bilirubin in the serum of a captive population of the mountain tortoise (Geochelone pardalis) (n = 13) were determined. Results varied considerably, particularly for most enzymes such as
AST
(11-113 U/l,ALT (1-72 U/l), CK (12-242 U/l), LD (147-2641 U/l) and ALP (56-168 U/l).
...
PMID:Selected biochemical parameters in captive mountain tortoises (Geochelone pardalis). 849 93
The anti-CD30 immunotoxin (IT) Ber-H2/saporin is effective in patients with refractory Hodgkin's disease. However, responses are short and partial, one of the main reasons being the inability to repeat IT doses because of formation of human antibodies against the murine antibody and/or the toxin. To overcome this problem, we constructed two new anti-CD30 ITs by covalently linking the mouse monoclonal antibody Ber-H2 to the type 1 ribosome-inactivating proteins (RIPs) momordin (MOM) and pokeweed antiviral protein from seeds (PAP-S), which do not cross-react with each other or with saporin. Both ITs inhibited protein synthesis by Hodgkin's disease and anaplastic large-cell lymphoma (ALCL)-derived CD30+ target cell lines with a very high efficiency (IC50 ranging from < 5 x 10(-13) M to 2.75 x 10(-11) M, as RIP). In a SCID mouse model of xenografted CD30+ human ALCL, a 3d treatment with non-toxin doses of Ber-H2/MOM (50%LD50), started 24 h after transplantation, prevented tumour development in about 40% of the animals and significantly delayed tumour growth rate in the others. Main toxicity signs in mice and rabbits were dose-related increase of serum transaminases (
AST
and ALT) and
creatine phosphokinase
(
CPK
). LD50 (as RIP) in Swiss mice was 7 mg/kg for Ber-H2/MOM and 0.45 mg/kg for Ber-H2/PAP-S. Sequential administration of two anti-CD30 ITs (Ber-H2/MOM and Ber-H2/saporin) was well tolerated and did not result in formation of antibodies cross-reacting and with the two plant toxins. The results presented in this paper suggest that in the future, sequential administration of anti-CD30 humanized antibodies linked to antigenically distinct type 1 RIPs (saporin, MOM, PAP-S) should be feasible.
...
PMID:Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice. 861 80
Endothelial damage within the sinusoids of the liver probably plays a key role in primary liver dysfunction following transplantation. The aim of this work was to study the serum levels of two potential markers of endothelial damage,
creatine kinase
-BB and soluble thrombomodulin, during human graft revascularization. Thirteen human liver grafts were preserved in UW solution (mean time: 13.8 h). Creatine kinase-BB and transaminase activities and soluble thrombomodulin levels were measured: 1) in effluent and 2) in serum samples sequentially collected before revascularization, then during the first 120 min of revascularization and first post-operative week. No correlation was observed between serum values (peak) and effluent values. In serum, pre-operative
creatine kinase
-BB activities were correlated with soluble thrombomodulin levels (p = 0.01). Both increased significantly during the first minutes of the revascularization, then decreased markedly. In contrast,
AST
activity was maximal at day 1. This detectable and early release of
creatine kinase
-BB and soluble thrombomodulin in blood is in keeping with the early occurence of endothelial damage. Together with previous data, these findings suggest that serum determination of these two markers may be a useful tool in the assessment of endothelial injury in liver transplantation.
...
PMID:Serum levels of endothelial injury markers creatine kinase-BB and soluble thrombomodulin during human liver transplantation. 887 93
We report here our experience with serum troponin T (TnT), measured with the sandwich immunoassay introduced by Boehringer Mannheim as a marker for myocardial infarction. We assayed TnT in serial serum samples from 30 patients with time courses of serum CK,
CK-MB
,
AST
, and LD that we consider typical of acute myocardial infarction (MI). In every patient but one, TnT rose in parallel with both
CK-MB
and
AST
, but remained elevated significantly longer. The ratios of the elevations of the different markers varied from patient to patient with marked variation in the ratio of TnT to
CK-MB
. There appeared to be a significant association between the magnitude of that ratio with the level of ALT.
...
PMID:Troponin-T as a serum marker for myocardial infarction. 913 99
Sixty-six Thoroughbred horses in training (2 or 3 years of age) were studied during one flat racing season, to investigate the relationship between age, sex, time of year, dietary electrolyte imbalances and plasma aspartate aminotransferase/
creatine kinase
(
AST
/CK) activities. Management and training variations were minimised. Between February to October, monthly 24 h post exercise samples were collected and analysed for
AST
and CK activities. Sex and/or age were shown to have a significant effect on the occurrence of high CK (> 100 iu/litre) and
AST
(> 300 iu/litre) activities. Fillies were more likely to have elevated CK and
AST
than colts. Two-year-olds tended to have higher
AST
activities than three-year-olds. Time of year had no significant effect on the number of animals with high or low activities. Fourteen animals had consistently raised plasma
AST
activities (median > 300 iu/litre). Eight of these raced and seven won at least one race. The average daily intake of calcium, sodium, phosphorus and potassium was determined at each sampling time. In eight of the horses, the fractional electrolyte excretion (FE) of phosphate (PO4) and sodium (Na) was determined monthly. FE values were also determined in three horses which had suffered repeated attacks of the equine rhabdomyolysis syndrome. The FE, PO4 and Na values reflected dietary intake of calcium, phosphorus and sodium respectively. It was not possible to determine any effect of training or a predisposition to equine rhabdomyolysis. No obvious differences were found between the resting thyroxine values of three animals with consistently low
AST
activities, six of those with consistently raised
AST
and three animals which had suffered repeated attacks of rhabdomyolysis.
...
PMID:Some factors influencing plasma AST/CK activities in thoroughbred racehorses. 925 10
A 13-year-old warmblood mare was presented because of progressive weight loss, general weakness and trembling. On examination the horse stood with its head lowered and the limbs placed under the body. On lifting its head spasms of the neck muscles could be observed. At the same time the horse developed trembling over the lower neck and muscle fasciculations continued over the whole body. Additional signs included frequent recumbency, polyphagia and facial hyperaesthesia. The horse showed no signs of ataxia. Haematology was normal. Blood biochemistry revealed slight increased aspartate aminotransferase (
AST
: 1060 U/I) and
creatine kinase
levels (CK: 441 U/I). Based on the clinical findings equine motor neuron disease was diagnosed. The horse was euthanatized due to poor prognosis and the progression of symptoms. The typical neurodegenerative changes found on histological examination of the spinal cord confirmed the diagnosis.
...
PMID:[Equine motor neuron disease (EMND). A case report]. 928 83
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>